programme aimed at making temazepam soft gels more resistant to misuse. Thus when the Home Office made its concern known the two companies were able, in consultation with the Home Office and the Medicines Control Agency, to replace the original liquid filled soft gelatin capsule with the gel filled product in a short time.
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It is important to note that ischaemic damage has also been reported after intra-arterial injection of the contents of a liquid filled temazepam capsule. Hudson et al reported focal rhabdomyolysis in a 28 year old woman after injection of 80 mg temazepam from a liquid filled capsule into the femoral artery.' Moreover, the development of an intravenous injection of temazepam for therapeutic use was abandoned because it was impossible to produce a formulation that did not cause unacceptable damage to the veins. 46 The venous damage found during the testing of these formulations was clearly due to the temazepam rather than any particular excipient(s).
In reformulating the liquid filled capsule to a gel filled product the options considered were deliberately constrained to exclude any harmful substances that might smack ofa punitive approach to preventing misuse. This was one of the reasons why the familiar macrogols, used previously in the liquid filled capsule, were chosen as solvents; these excipients also had the advantage of posing no new problems regarding stability.
In conclusion, though we agree that serious risks are associated with inadvertent intra-arterial injection of the gel fill of temazepam capsules, the evidence indicates that these risks are probably due to the intrinsic physicochemical properties of temazepam rather than to any particular formula- Temazepam was used to increase the effect of the opiate and to relieve the symptoms of other drugs. Although stiff gel capsules, supposed to be resistant to misuse, were introduced in November 1989, anecdotal evidence from our sample suggests that the content of the capsules can be heated in a spoon and injected. Roy N Scott and colleagues also report this method of misusing temazepam.' Temazepam was never the drug of first choice among our sample of drug users. In most cases heroin was the drug of both first and second choice. Sixty eight of those surveyed had injected heroin, and an additional eight had snorted or smoked it. Over half had injected cocaine. Sixty seven had taken benzodiazepines by various routes. Fifty two had taken heroin or methadone in the previous week, and 31 had taken benzodiazepines. Twenty of those taking benzodiazepines had used temazepam, and it was the only benzodiazepine that was injected. Men were more likely than women to inject temazepam. Four of those injecting temazepam did so daily and eight injected it two or three times a week. Five injected it once a week. Thirteen injected [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 
